Literature DB >> 7832782

Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.

Y Xiong1, E W Westhead, L L Slakey.   

Abstract

Three phosphodiesterase (PDE) isoenzymes were separated by Mono Q h.p.l.c. column chromatography from the soluble fraction of a homogenate of pig aortic smooth muscle cells. The first peak of PDE activity was stimulated by calmodulin in the presence of calcium. The second broad peak contained at least two activities, which were sensitive to inhibition by CI-930 or rolipram respectively. The distribution of total cellular enzyme activity in different subcellular fractions was also determined. The majority (78%) of the total activity was present in the cytosolic fraction, 18% of activity was in a membrane-bound form and 4% of activity was associated with the cytoskeleton. Rolipram-sensitive PDE was present predominantly in the cytosolic fraction, whereas cyclic GMP-inhibited, CI-930-sensitive PDE was evenly distributed between the cytosolic and particulate fractions. All of the calmodulin-dependent PDE activity was found in the soluble fraction. CI-930 and rolipram enhanced, by 2-fold and 3-4-fold respectively, the adenosine-stimulated rise in cellular cyclic AMP level. The increase in cyclic AMP levels due to CI-930 or rolipram was dose-dependent. Removal of adenosine once cyclic AMP had risen resulted in a rapid fall in cyclic AMP levels even in the presence of rolipram and CI-930. M&B 22,948, the calmodulin-dependent PDE inhibitor, caused less than a 25% increase of the adenosine-stimulated cyclic AMP levels by itself, but it contributed substantially to controlling the cyclic AMP levels after the removal of adenosine when used together with CI-930 and rolipram. These phenomena suggested that all three PDE isoenzymes participated in modulating cellular cyclic AMP levels after adenosine stimulation, and that differential importance of the individual isoenzymes depends on cellular cyclic AMP levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7832782      PMCID: PMC1136408          DOI: 10.1042/bj3050627

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Radioimmunoassay of cyclic AMP and cyclic GMP.

Authors:  G Brooker; J F Harper; W L Terasaki; R D Moylan
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

Review 2.  A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.

Authors:  R E Weishaar; M H Cain; J A Bristol
Journal:  J Med Chem       Date:  1985-05       Impact factor: 7.446

3.  The enthalpy of hydrolysis of various 3',5'-and 2',3'-cyclic nucleotides.

Authors:  S A Rudolph; E M Johnson; P Greengard
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

4.  Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle.

Authors:  J B Polson; J J Krzanowski; A Szentivanyi
Journal:  Biochem Pharmacol       Date:  1982-11-01       Impact factor: 5.858

5.  Catalytic and kinetic properties of purified high-affinity cyclic AMP phosphodiesterase from dog kidney.

Authors:  P M Epstein; S J Strada; K Sarada; W J Thompson
Journal:  Arch Biochem Biophys       Date:  1982-10-01       Impact factor: 4.013

6.  Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.

Authors:  T M Keravis; J N Wells; J G Hardman
Journal:  Biochim Biophys Acta       Date:  1980

7.  Turnover of adenosine 3',5'-monophosphate in WI-38 cultured fibroblasts.

Authors:  R Barber; K P Ray; R W Butcher
Journal:  Biochemistry       Date:  1980-06-10       Impact factor: 3.162

8.  Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.

Authors:  M Hagiwara; T Endo; H Hidaka
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

9.  Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.

Authors:  P G Grant; R W Colman
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

10.  Effect of adenosine on synthesis and release of cyclic AMP by cultured vascular cells from swine.

Authors:  S J Goldman; E S Dickinson; L L Slakey
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983
View more
  2 in total

1.  Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

Authors:  Y H Choi; D Ekholm; J Krall; F Ahmad; E Degerman; V C Manganiello; M A Movsesian
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

2.  Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model.

Authors:  Y Inoue; K Toga; T Sudo; K Tachibana; S Tochizawa; Y Kimura; Y Yoshida; H Hidaka
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.